Clinical trial
A Randomized, Placebo-Controlled, Multi-Center Study of Oral Beclomethasone Dipropionate With Ten Days of Prednisone for Treatment of Gastrointestinal Graft Vs. Host Disease
NCT00233896 is registered in ClinicalTrials.gov with Enteron Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Placebo-Controlled, Multi-Center Study of Oral Beclomethasone Dipropionate With Ten Days of Prednisone for Treatment of Gastrointestinal Graft Vs. Host Disease
- Lead sponsor
- Enteron Pharmaceuticals
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 31, 2001
- Completion date
- December 31, 2004
- Enrollment
- 130
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastrointestinal graft-versus-host disease, graft vs host disease